| P2093 | author name string | Howard S Smith | |
| | Eric J Smith | |
| | Benjamin R Smith | |
| P2860 | cites work | Acetaminophen for osteoarthritis | Q24244676 |
| | Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials | Q24546221 |
| | Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study | Q28195282 |
| | Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib | Q28222097 |
| | Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society | Q28251589 |
| | Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. | Q30369899 |
| | EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q33260652 |
| | OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines | Q33320085 |
| | Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data | Q33516685 |
| | OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. | Q33532831 |
| | Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study | Q33857444 |
| | Osteoarthritis of the hip or knee: which coexisting disorders are disabling? | Q33884900 |
| | SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants | Q33989845 |
| | Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis | Q34088744 |
| | A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. | Q50900594 |
| | Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. | Q51217024 |
| | Sensitization in patients with painful knee osteoarthritis | Q60681112 |
| | Increased movement pain in osteoarthritis of the hands is associated with Aβ-mediated cutaneous mechanical sensitivity | Q60709062 |
| | Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities | Q67599101 |
| | Pain threshold analysis in patients with osteoarthrosis of hip | Q68794034 |
| | The reliability and validity of pain threshold measurements in osteoarthritis of the knee | Q71541592 |
| | Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study | Q74101014 |
| | Co-morbidities of patients with knee osteoarthritis | Q83991040 |
| | Pharmacological management of persistent pain in older persons | Q84159023 |
| | A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee | Q84524860 |
| | An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride). | Q44668420 |
| | The Diversion of Ultram, Ultracet, and generic tramadol HCL. | Q44725862 |
| | A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis | Q45101921 |
| | Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. | Q45922836 |
| | FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. | Q45923695 |
| | A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. | Q45996339 |
| | Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis | Q46043948 |
| | The nerve of osteoarthritis pain | Q46374605 |
| | Tramadol addiction. | Q46439725 |
| | Severe tramadol addiction in a 61 year-old woman without a history of substance abuse | Q46545355 |
| | Two to five year follow-up of the LPM ceramic coated proximal interphalangeal joint arthroplasty | Q47855233 |
| | Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. | Q48473429 |
| | Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. | Q48703400 |
| | Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale | Q48823789 |
| | Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale | Q48823796 |
| | Will this patient develop persistent disabling low back pain? | Q34108771 |
| | Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis | Q34165468 |
| | Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur | Q34183294 |
| | Physical dependence potential of daily tramadol dosing in humans | Q34527297 |
| | Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial | Q34544702 |
| | Chapter 4. European guidelines for the management of chronic nonspecific low back pain. | Q34565815 |
| | Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association | Q34576407 |
| | Population-based surveillance for acute liver failure | Q34645492 |
| | Acetaminophen hepatotoxicity and acute liver failure | Q34657996 |
| | The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia | Q35092990 |
| | High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies. | Q35163022 |
| | Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. | Q35760454 |
| | Effect of tens on pain in relation to central sensitization in patients with osteoarthritis of the knee: study protocol of a randomized controlled trial | Q35839329 |
| | Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials | Q35961855 |
| | Pyrolytic carbon proximal interphalangeal joint arthroplasty: results with minimum two-year follow-up evaluation | Q36705640 |
| | Duloxetine in treatment of refractory chronic tennis elbow: two case reports | Q36915267 |
| | Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study | Q37141254 |
| | A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis | Q37363371 |
| | Duloxetine: in patients with fibromyalgia | Q37523865 |
| | Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy | Q37766405 |
| | Opioid Therapy for Osteoarthritis and Chronic Low Back Pain | Q37810414 |
| | Duloxetine: clinical pharmacokinetics and drug interactions | Q37848815 |
| | Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment | Q37883773 |
| | Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial | Q38482376 |
| | Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial | Q39283052 |
| | A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain | Q39312509 |
| | Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain | Q39373636 |
| | Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief | Q39424336 |
| | Efficacy and safety of duloxetine in patients with chronic low back pain | Q42165682 |
| | Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure | Q42277500 |
| | Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults | Q42610198 |
| | Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial | Q43062358 |
| | Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies | Q43096660 |
| | Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis | Q43236927 |
| | Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers | Q43258644 |
| | Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin | Q43266149 |
| | Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial | Q43300193 |
| | Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. | Q43560404 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | pain management | Q621261 |
| | musculoskeletal pain | Q45048948 |
| P304 | page(s) | 267-277 | |
| P577 | publication date | 2012-06-19 | |
| P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
| P1476 | title | Duloxetine in the management of chronic musculoskeletal pain | |
| P478 | volume | 8 | |